BiomX Inc. — Director's Dealing 2022

Mar 31, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2022-03-29

Reporting Person: Amusa Gbolahan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-29	Common Stock Options - Right to Buy	$1.41	A	20500	Acquired	2032-03-29	Common Stock (20500)	Direct

Footnotes

F1: The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 29, 2023, and the remainder vesting in 12 equal quarterly installments over three years.